Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of OSHO Induction vs German Standard in AML
NCT01414231Phase 3Unknown
- Sponsor
- Leipzig University
- Start
- Apr 2002
- Primary completion
- Dec 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of cytarabine in acute myeloid leukemia (AML), sponsored by Leipzig University. Status: unknown.
02
Drugs
cytarabine
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on NCT01414231.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01414231.